心力衰竭器械治疗：诊断、检测与疾病修正
Devices in heart failure; diagnosis, detection and disease modification.
机构信息
Division of Cardiovascular and Diabetes Research, Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Clarendon Way, Leeds LS29JT, UK.
出版信息
Br Med Bull. 2018 Mar 1;125(1):91-102. doi: 10.1093/bmb/ldx051.
INTRODUCTION/BACKGROUND: Implantable cardiac devices are widely used in chronic heart failure (CHF) therapy. This review covers current CHF treatment with electronic cardiac devices, areas of discussion and emerging technologies.
SOURCES OF DATA
A comprehensive search of available literature resources including Pubmed, MEDLINE and EMBASE was performed. National and international guidelines were accessed.
AREAS OF AGREEMENT
Excessive right ventricular pacing is detrimental to cardiac function. Cardiac resynchronization therapy is beneficial in specific individuals with CHF.
AREAS OF CONTROVERSY
Implantable cardioverter defibrillators might not benefit all. Optimizing CRT delivery. Remote monitoring seems not to be of benefit in CHF.
GROWING POINTS
Device-based optimization.
AREAS TIMELY FOR DEVELOPING RESEARCH
Personalization of device therapy. Focussing implantable cardioverter defibrillator therapy. What to do at implantable cardioverter defibrillator box change?
简介/背景：植入式心脏装置在慢性心力衰竭（CHF）治疗中得到了广泛应用。本综述涵盖了当前使用电子心脏装置治疗 CHF 的情况、讨论领域和新兴技术。
数据来源
对包括 Pubmed、MEDLINE 和 EMBASE 在内的现有文献资源进行了全面检索，并查阅了国家和国际指南。
达成一致的领域
右心室过度起搏不利于心脏功能。心脏再同步治疗对特定的 CHF 患者有益。
存在争议的领域
植入式心脏复律除颤器可能对所有人都没有益处。优化 CRT 输送。远程监测似乎对 CHF 没有益处。
有待研究的新领域
基于设备的优化。
及时开展研究的领域
设备治疗的个性化。关注植入式心脏复律除颤器治疗。在更换植入式心脏复律除颤器盒时该怎么做？
Zotero 插件